Literature DB >> 21367947

Does vitamin D deficiency contribute to increased rates of cardiovascular disease and type 2 diabetes in African Americans?

Susan S Harris1.   

Abstract

African Americans have higher rates of type 2 diabetes (T2D) and some forms of cardiovascular disease (CVD) than do European Americans. African Americans also have much higher rates of vitamin D deficiency. There is emerging evidence that vitamin D deficiency may be a risk factor for hypertension, T2D, and CVD, but the extent to which racial disparities in disease rates are explained by racial differences in vitamin D status is uncertain. Despite a large number of observational studies and a limited number of clinical trials that examined 25-hydroxyvitamin D [25(OH)D] concentrations as a potential determinant of CVD and T2D or its precursors, it remains uncertain whether improving vitamin D status would reduce risk of these conditions in the general US population or in African Americans specifically. However, if the associations reported from the observational studies are of the estimated magnitudes and causal, vitamin D supplementation could potentially have a strong preventive effect on some of these conditions and could reduce race-related disparities in their prevalence. Because of the low 25(OH)D concentrations of many, if not most, African Americans, and the low risk associated with vitamin D supplementation, it is important to obtain more definitive answers to these questions.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21367947     DOI: 10.3945/ajcn.110.003491

Source DB:  PubMed          Journal:  Am J Clin Nutr        ISSN: 0002-9165            Impact factor:   7.045


  22 in total

1.  Serum 25-Hydroxyvitamin D Values and Risk of All-Cause and Cause-Specific Mortality: A Population-Based Cohort Study.

Authors:  Daniel V Dudenkov; Kristin C Mara; Tanya M Petterson; Julie A Maxson; Tom D Thacher
Journal:  Mayo Clin Proc       Date:  2018-05-02       Impact factor: 7.616

2.  Dose response to vitamin D supplementation in African Americans: results of a 4-arm, randomized, placebo-controlled trial.

Authors:  Kimmie Ng; Jamil B Scott; Bettina F Drake; Andrew T Chan; Bruce W Hollis; Paulette D Chandler; Gary G Bennett; Edward L Giovannucci; Elizabeth Gonzalez-Suarez; Jeffrey A Meyerhardt; Karen M Emmons; Charles S Fuchs
Journal:  Am J Clin Nutr       Date:  2013-12-24       Impact factor: 7.045

3.  Vitamin D deficiency is associated with silent coronary artery disease in cardiovascularly asymptomatic African Americans with HIV infection.

Authors:  Hong Lai; Gary Gerstenblith; Elliot K Fishman; Jeffrey Brinker; Thomas Kickler; Wenjing Tong; Sundeepan Bhatia; Tai Hong; Shaoguang Chen; Ji Li; Barbara Detrick; Shenghan Lai
Journal:  Clin Infect Dis       Date:  2012-03-15       Impact factor: 9.079

4.  The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease.

Authors:  Joann E Manson; Shari S Bassuk; I-Min Lee; Nancy R Cook; Michelle A Albert; David Gordon; Elaine Zaharris; Jean G Macfadyen; Eleanor Danielson; Jennifer Lin; Shumin M Zhang; Julie E Buring
Journal:  Contemp Clin Trials       Date:  2011-10-02       Impact factor: 2.226

5.  Plasma 25-hydroxyvitamin D and risk of metabolic syndrome: an ancillary analysis in the Diabetes Prevention Program.

Authors:  J Mitri; J Nelson; R Ruthazer; C Garganta; D M Nathan; F B Hu; B Dawson-Hughes; A G Pittas
Journal:  Eur J Clin Nutr       Date:  2014-01-22       Impact factor: 4.016

6.  Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial.

Authors:  Joanna Mitri; Bess Dawson-Hughes; Frank B Hu; Anastassios G Pittas
Journal:  Am J Clin Nutr       Date:  2011-06-29       Impact factor: 7.045

7.  Neighborhood poverty, park use, and park-based physical activity in a Southern California city.

Authors:  Deborah A Cohen; Bing Han; Kathryn Pitkin Derose; Stephanie Williamson; Terry Marsh; Jodi Rudick; Thomas L McKenzie
Journal:  Soc Sci Med       Date:  2012-09-12       Impact factor: 4.634

8.  Ethnicity/culture modulates the relationships of the haptoglobin (Hp) 1-1 phenotype with cognitive function in older individuals with type 2 diabetes.

Authors:  Elizabeth Guerrero-Berroa; Ramit Ravona-Springer; Anthony Heymann; James Schmeidler; Hadas Hoffman; Rachel Preiss; Keren Koifmann; Lior Greenbaum; Andrew Levy; Jeremy M Silverman; Derek Leroith; Mary Sano; Michal Schnaider-Beeri
Journal:  Int J Geriatr Psychiatry       Date:  2015-09-21       Impact factor: 3.485

9.  Effects of calcium-vitamin D co-supplementation on metabolic profiles in vitamin D insufficient people with type 2 diabetes: a randomised controlled clinical trial.

Authors:  Marjan Tabesh; Leila Azadbakht; Elham Faghihimani; Maryam Tabesh; Ahmad Esmaillzadeh
Journal:  Diabetologia       Date:  2014-07-10       Impact factor: 10.122

10.  Baseline characteristics of participants in the VITamin D and OmegA-3 TriaL (VITAL).

Authors:  Shari S Bassuk; JoAnn E Manson; I-Min Lee; Nancy R Cook; William G Christen; Vadim Y Bubes; David S Gordon; Trisha Copeland; Georgina Friedenberg; Denise M D'Agostino; Claire Y Ridge; Jean G MacFadyen; Kate Kalan; Julie E Buring
Journal:  Contemp Clin Trials       Date:  2016-01-06       Impact factor: 2.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.